Results 31 to 40 of about 19,912,299 (390)

Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation

open access: yesNature Communications, 2019
Hepatitis delta virus (HDV) depends on the helper function of hepatitis B virus (HBV), which provides the envelope proteins for progeny virus secretion. Current infection-competent cell culture models do not support assembly and secretion of HDV.
Florian A. Lempp   +7 more
semanticscholar   +1 more source

Community sewage sensors towards evaluation of drug use trends: detection of cocaine in wastewater with DNA-directed immobilization aptamer sensors [PDF]

open access: yes, 2016
Illicit drug use has a global concern and effective monitoring and interventions are highly required to combat drug abuse. Wastewater-based epidemiology (WBE) is an innovative and cost-effective approach to evaluate community-wide drug use trends ...
Castrignanò, Erika   +4 more
core   +1 more source

Ceftobiprole: drug evaluation and place in therapy

open access: yesExpert Review of Anti-Infective Therapy, 2019
Introduction: Ceftobiprole is a fifth-generation cephalosporin with a broad spectrum of antimicrobial activity, including also methicillin-resistant Staphylococcus aureus (MRSA). Ceftobiprole is approved for the treatment of community-acquired pneumonia (
D. Giacobbe   +10 more
semanticscholar   +1 more source

Multiplex PCR-based titration (MPBT) assay for determination of infectious titers of the three Sabin strains of live poliovirus vaccine

open access: yesVirology Journal, 2019
Background Conventional assays to titrate polioviruses usually test serial dilutions inoculated into replicate cell cultures to determine a 50% cytopathic endpoint, a process that is both time-consuming and laborious.
Hasmik Manukyan   +5 more
doaj   +1 more source

Target-based evaluation of ‘drug-like’ properties and ligand efficiencies

open access: yesJournal of Medicinal Chemistry, 2021
Physicochemical descriptors commonly used to define ‘drug-likeness’, and ligand efficiency measures, are assessed for their ability to differentiate marketed drugs from compounds reported to bind to their efficacious target or targets.
P. Leeson   +6 more
semanticscholar   +1 more source

Dose-finding studies in drug development for rare genetic diseases

open access: yesOrphanet Journal of Rare Diseases, 2022
Background The small patient populations inherent to rare genetic diseases present many challenges to the traditional drug development paradigm. One major challenge is generating sufficient data in early phase studies to inform dose selection for later ...
Lingshan Wang   +6 more
doaj   +1 more source

Towards a transparent, credible, evidence-based decision-making process of new drug listing on the Hong Kong Hospital Authority Drug Formulary: challenges and suggestions [PDF]

open access: yes, 2017
The aim of this article is to describe the process, evaluation criteria, and possible outcomes of decision-making for new drugs listed in the Hong Kong Hospital Authority Drug Formulary in comparison to the health technology assessment (HTA) policy ...
Cheung, Bernard M.Y.   +2 more
core   +2 more sources

Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles [PDF]

open access: yes, 2004
The study reports the initial biological evaluation of targeted polymeric glycol chitosan vesicles as carrier systems for doxorubicin (Dox). Transferrin (Tf) was covalently bound to the Dox-loaded palmitoylated glycol chitosan (GCP) vesicles using ...
Couet, William   +5 more
core   +1 more source

Organotypic brain explant culture as a drug evaluation system for malignant brain tumors

open access: yesCancer Medicine, 2017
Therapeutic options for malignant brain tumors are limited, with new drugs being continuously evaluated. Organotypic brain slice culture has been adopted for neuroscience studies as a system that preserves brain architecture, cellular function, and the ...
N. Minami   +11 more
semanticscholar   +1 more source

Evaluation of linear classifiers on articles containing pharmacokinetic evidence of drug-drug interactions

open access: yes, 2012
Background. Drug-drug interaction (DDI) is a major cause of morbidity and mortality. [...] Biomedical literature mining can aid DDI research by extracting relevant DDI signals from either the published literature or large clinical databases.
Kolchinsky, Artemy   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy